The binding of C5-alkynyl and alkylfurano[2,3-d]pyrimidine glucopyranonucleosides to glycogen phosphorylase b: synthesis, biochemical and biological assessment.

Abstract

C5-alkynyl and alkylfurano[2,3-d]pyrimidine glucopyranonucleosides have been synthesized and studied as inhibitors of glycogen phosphorylase b (GPb). Kinetic experiments have shown that most of these compounds were low micromolar inhibitors of the enzyme. The best inhibitor was 1-(β-D-glucopyranosyl)-5-ethynyluracil (K(i)=4.7 μM). Crystallographic analysis of these compounds in complex with GPb revealed that inhibitors with a long C5-alkynyl group exploited interactions with β-pocket of the active site and induced significant conformational changes of the 280s loop compared to GPb in complex with compounds with a short C5-alkynyl group. The results highlight the importance in the length of the aliphatic groups used to enhance inhibitory potency for the exploitation of the hydrophobic β-pocket. The best of the inhibitors had also a moderate effect on glycogenolysis in the cellular lever with an IC(50) value of 291.4 μM.

DOI: 10.1016/j.ejmech.2012.06.029

8 Figures and Tables

Cite this paper

@article{Kantsadi2012TheBO, title={The binding of C5-alkynyl and alkylfurano[2,3-d]pyrimidine glucopyranonucleosides to glycogen phosphorylase b: synthesis, biochemical and biological assessment.}, author={Anastasia L Kantsadi and Stella Manta and A M G Psarra and Athina Dimopoulou and Christos Kiritsis and Vanessa Parmenopoulou and Vicky T Skamnaki and Panagiotis Zoumpoulakis and Spyros E Zographos and Demetres D Leonidas and Dimitri Komiotis}, journal={European journal of medicinal chemistry}, year={2012}, volume={54}, pages={740-9} }